SCHEMBL5731667

SCHEMBL5731667

Nc1cn(N)cc2cnnc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722172 0.58 GABRG2 (0.35) —
SCHEMBL3466863 0.51 ADORA2A (0.32) —
SCHEMBL17437633 0.51 — —
SCHEMBL4153983 0.49 — —
SCHEMBL6278613 0.49 — —
Hydrochloric Acid SCHEMBL15903538 0.47 PTK2 (0.33) —
SCHEMBL15962191 0.47 — —
SCHEMBL19462404 0.47 — —
SCHEMBL30711609 0.46 — —
SCHEMBL13158539 0.46 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620437-A1 5,7-DIAMINOPYRAZOLO[4,3-D]PYRIMIDINES USEFUL IN THE TRAETMENT OF HYPERTENSION Pfizer Limited (GB) 2006-02-01 — — EP claimed
WO-2004096810-A1 5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION PFIZER LIMITED (GB) 2004-11-11 — — WO claimed
EP-1689752-A1 PYRAZOLOPYRIMIDINES Pfizer Limited (GB) 2006-08-16 — — EP disclosed
WO-2005049617-A1 PYRAZOLOPYRIMIDINES PFIZER LIMITED (GB) 2005-06-02 — — WO disclosed
Send feedback